* Partner: SEED Capital Management I/S
* Director: Symbion Capital I A/S
* Chairman of the Board:OncoTaq Pharmaceuticals ApS
* Member of the Board: Celltrix AB, Aresa A/S, Evolva A/S, Zgene A/S, NeuroKey A/S and Valderm ApS
Career:
Carsten holds an MSc in biology and a PhD in immunology from the University of Copenhagen and the State Serum Institute. He has 11 years of operational experience in the pharmaceutical industry and has been Director of Research at ALK-Abelló A/S. He has held senior management positions in the biotechnology industry and, as an entrepreneur, he co-founded two biotech companies. He was a partner in Danske Private Equity Life Science prior to joining DTU-Innovation A/S and SEED Capital Denmark.
